Prof. Robert J Gil

Gil Robert J

My lectures

From the session: Hot line - PCI in practice

Regular DES versus dedicated bifurcation sirolimus-eluting stent in the coronary bifurcation treatment: randomised, multicentre, open-label, controlled POLBOS II trial

Speaker: R.J. Gil
From the session: Clinical updates on dedicated devices for bifurcation lesions

Regular DES versus dedicated bifurcation sirolimus-eluting stent in the coronary bifurcation treatment: randomised, multicentre, open-label, controlled POLBOS II trial

Speaker: R.J. Gil
From the session: Transcatheter valve interventions: new indications, new valves and how to treat complications - The best of the Warsaw Course on Cardiovascular Interventions (WCCI) 2015

Session objectives

Speaker: R.J. Gil
From the session: PCI in ACS: from success to defeat - The best of the Warsaw Course on Cardiovascular Interventions (WCCI) 2014

Introduction and objectives

Speaker: R.J. Gil
From the session: Moderated posters 4

Regular DES versus dedicated bifurcation paclitaxel-eluting stent in coronary bifurcation treatment - Interim analysis of randomised POLBOS study

Speaker: R.J. Gil

Hypertrophic cardiomyopathy – interventional treatment

Speaker: R.J. Gil
Fellows Course Krakow 2011

Bifurcation dedicated stents (BDS)

Speaker: R.J. Gil
Fellows Course Krakow 2011
From the session: Primary PCI in STEMI - towards optimal results in complex lesions

How would I treat?

Speaker: R.J. Gil
From the session: Primary PCI in STEMI - towards optimal results in complex lesions

How would I treat?

Speaker: R.J. Gil
From the session: Dedicated stents for bifurcation lesion PCI

The dedicated drug-eluting Bifurcation Optimisation Stent System (BiOSS) Registry first-in-human results

Speaker: R.J. Gil

Percutaneous approach to patients with hypertrophic cardiomyopathy

Speaker: R.J. Gil
Fellows Course Krakow 2010

Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Speaker: R.J. Gil

PCI is successful but what next?

Speaker: R.J. Gil

Role of IVUS and FFR before and during intervention

Speaker: R.J. Gil

Hypertrophic obstructive cardiomyopathy

Speaker: R.J. Gil
From the session: Emergency coronary and non-coronary interventions

Conclusion and take-home message

Speaker: R.J. Gil
From the session: Emergency coronary and non-coronary interventions

Case 3 - Discussion and interactivity with the audience

Speaker: R.J. Gil
From the session: Emergency coronary and non-coronary interventions

Case 2 - Discussion and interactivity with the audience

Speaker: R.J. Gil
From the session: Emergency coronary and non-coronary interventions

Case 1 - Discussion and interactivity with the audience

Speaker: R.J. Gil
From the session: Emergency coronary and non-coronary interventions

Introduction and learning objectives

Speaker: R.J. Gil